Clinical Trial Update: Smell in Covid-19 and Efficacy of Nasal Theophylline [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of nasal theophylline for Covid-19 related smell disorders (anosmia/hyposmia) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olfactory Disorder

Drugs mentioned

• Theophylline nasal formulation (theophylline)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Covid19, Anosmia | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24